These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38294612)

  • 41. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
    Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
    J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
    Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
    Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study.
    Partelli S; Ramage JK; Massironi S; Zerbi A; Kim HB; Niccoli P; Panzuto F; Landoni L; Tomazic A; Ibrahim T; Kaltsas G; Bertani E; Sauvanet A; Segelov E; Caplin M; Coppa J; Armstrong T; Weickert MO; Butturini G; Staettner S; Boesch F; Cives M; Moulton CA; He J; Selberherr A; Twito O; Castaldi A; De Angelis CG; Gaujoux S; Almeamar H; Frilling A; Vigia E; Wilson C; Muffatti F; Srirajaskanthan R; Invernizzi P; Lania A; Kwon W; Ewald J; Rinzivillo M; Nessi C; Smid LM; Gardini A; Tsoli M; Picardi EE; Hentic O; Croagh D; Toumpanakis C; Citterio D; Ramsey E; Mosterman B; Regi P; Gasteiger S; Rossi RE; Smiroldo V; Jang JY; Falconi M
    Front Med (Lausanne); 2020; 7():598438. PubMed ID: 33425946
    [No Abstract]   [Full Text] [Related]  

  • 45. Racial and ethnic differences in reconstructive surgery for apical vaginal prolapse.
    Boyd BAJ; Winkelman WD; Mishra K; Vittinghoff E; Jacoby VL
    Am J Obstet Gynecol; 2021 Oct; 225(4):405.e1-405.e7. PubMed ID: 33984303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
    Matsumoto K; Fujimori N; Hata Y; Minoda Y; Murakami M; Teramatsu K; Takamatsu Y; Takeno A; Oono T; Ihara E; Nakata K; Nakamura M; Yamamoto T; Koga Y; Oda Y; Ito T; Ogawa Y
    Dig Dis; 2023; 41(2):316-324. PubMed ID: 35588707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
    Hao S; Snyder RA; Irish W; Parikh AA
    PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
    Shavers VL; Brown ML; Potosky AL; Klabunde CN; Davis WW; Moul JW; Fahey A
    J Gen Intern Med; 2004 Feb; 19(2):146-55. PubMed ID: 15009794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Racial/ethnic patterns of care for pancreatic cancer.
    Shavers VL; Harlan LC; Jackson M; Robinson J
    J Palliat Med; 2009 Jul; 12(7):623-30. PubMed ID: 19594347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancer.
    Revels SL; Banerjee M; Yin H; Sonnenday CJ; Birkmeyer JD
    J Am Coll Surg; 2013 Feb; 216(2):312-9. PubMed ID: 23195204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.
    Landry CS; Lin HY; Phan A; Charnsangavej C; Abdalla EK; Aloia T; Nicolas Vauthey J; Katz MH; Yao JC; Fleming JB
    World J Surg; 2013 Jul; 37(7):1695-700. PubMed ID: 23657749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the Number of National Database Research Studies in Musculoskeletal Sarcoma Increasing, and Are These Studies Reliable?
    Lawrenz JM; Johnson SR; Hajdu KS; Chi A; Bendfeldt GA; Kang H; Halpern JL; Holt GE; Schwartz HS
    Clin Orthop Relat Res; 2023 Mar; 481(3):491-508. PubMed ID: 35767810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National disparities in minimally invasive surgery for pancreatic tumors.
    Gabriel E; Thirunavukarasu P; Attwood K; Nurkin SJ
    Surg Endosc; 2017 Jan; 31(1):398-409. PubMed ID: 27412124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?
    Fitzgerald TL; Dennis SO; Kachare SD; Vohra NA; Zervos EE
    Surgery; 2015 Aug; 158(2):466-71. PubMed ID: 26013986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
    Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
    J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management.
    Babu R; Sharma R; Bagley JH; Hatef J; Friedman AH; Adamson C
    J Neurosurg; 2013 Jul; 119(1):121-30. PubMed ID: 23432451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.